These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1645517)

  • 1. Positron emission tomography as a research tool in the investigation of psychiatric and psychological disorders.
    Jones AK; Friston K; Dolan R
    Baillieres Clin Endocrinol Metab; 1991 Mar; 5(1):187-203. PubMed ID: 1645517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography.
    Mayberg HS; Sadzot B; Meltzer CC; Fisher RS; Lesser RP; Dannals RF; Lever JR; Wilson AA; Ravert HT; Wagner HN
    Ann Neurol; 1991 Jul; 30(1):3-11. PubMed ID: 1656846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography receptor studies.
    Duncan JS
    Adv Neurol; 1999; 79():893-9. PubMed ID: 10514872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of positron emission tomography in psychiatry].
    Degrell I; Berecz R; Glaub T; Lengyel Z; Egerházi A; Szakáll S; Trón L
    Orv Hetil; 2002 May; 143(21 Suppl 3):1311-4. PubMed ID: 12077925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of positron emission tomography in psychiatry.
    Parsey RV; Mann JJ
    Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.
    Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM
    J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography in psychiatry.
    Wiesel FA
    Psychiatr Dev; 1989; 7(1):19-47. PubMed ID: 2529539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Survey of Molecular Imaging of Opioid Receptors.
    Cumming P; Marton J; Lilius TO; Olberg DE; Rominger A
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging opiate receptors in the human brain with positron emission tomography. Potential applications for drug addiction research.
    Sadzot B; Mayberg HS; Frost JJ
    Acta Psychiatr Belg; 1990; 90(1):9-19. PubMed ID: 1670391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
    Tauscher J; Kapur S; Verhoeff NP; Hussey DF; Daskalakis ZJ; Tauscher-Wisniewski S; Wilson AA; Houle S; Kasper S; Zipursky RB
    Arch Gen Psychiatry; 2002 Jun; 59(6):514-20. PubMed ID: 12044193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical impact of cerebral dopamine-D2 receptor scintigraphy].
    Larisch R; Klimke A
    Nuklearmedizin; 1998; 37(7):245-50. PubMed ID: 9830615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroreceptor imaging in psychiatric disorders.
    Frankle WG; Laruelle M
    Ann Nucl Med; 2002 Nov; 16(7):437-46. PubMed ID: 12508833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography.
    Jones AK; Kitchen ND; Watabe H; Cunningham VJ; Jones T; Luthra SK; Thomas DG
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):803-8. PubMed ID: 10413036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain and opiate receptors: considerations for the design of positron emission tomography studies.
    Sadzot B; Frost JJ
    Anesth Prog; 1990; 37(2-3):113-20. PubMed ID: 1964768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse.
    Volkow ND; Fowler JS
    Semin Nucl Med; 1992 Oct; 22(4):254-67. PubMed ID: 1439871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis.
    Jones AK; Cunningham VJ; Ha-Kawa S; Fujiwara T; Luthra SK; Silva S; Derbyshire S; Jones T
    Br J Rheumatol; 1994 Oct; 33(10):909-16. PubMed ID: 7921749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?
    Wiesel FA
    J Neural Transm Suppl; 1992; 37():1-18. PubMed ID: 1402849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What to learn from in vivo opioidergic brain imaging?
    Sprenger T; Berthele A; Platzer S; Boecker H; Tölle TR
    Eur J Pain; 2005 Apr; 9(2):117-21. PubMed ID: 15737798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols.
    Jones AK; Cunningham VJ; Ha-Kawa SK; Fujiwara T; Liyii Q; Luthra SK; Ashburner J; Osman S; Jones T
    J Neurosci Methods; 1994 Mar; 51(2):123-34. PubMed ID: 8051944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantification of opiate receptors in man by positron emission tomography. Potential applications to the study of pain.
    Sadzot B; Mayberg HS; Frost JJ
    Neurophysiol Clin; 1990 Nov; 20(5):323-34. PubMed ID: 1965452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.